Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-25-013974

Director acquired 1,454 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Holder Michael Director 2025-05-19 Option exercise +1,454 7,997 D
Derivatives
Holder Michael Director 2025-05-19 Option exercise · Restricted Stock Units −1,454 18,181 D
Loading xslF345X05/form4-05212025_090559.xml…